Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,211,702 papers from all fields of science
Search
Sign In
Create Free Account
diphenylcyclopropenone
Known as:
2,3-diphenyl-2-cyclopropen-1-one
, DPCP
, Diphencyprone
A synthetic, potent allergic contact sensitizer with potential immunostimulatory activity. After sensitization process by repeated topical…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Cyclopropanes
Narrower (1)
diphenylcyclopropenone monohydrate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.
Woan‐Ruoh Lee
,
S. Shen
,
I. Aljuffali
,
Yi-ching Li
,
Jia-You Fang
Journal of Pharmacy and Science
2014
Corpus ID: 23285301
Alopecia usually cannot be cured because of the available drug therapy being unsatisfactory. To improve the efficiency of…
Expand
Review
2012
Review
2012
Topical treatments for cutaneous warts.
C. Kwok
,
S. Gibbs
,
C. Bennett
,
R. Holland
,
R. Abbott
Cochrane Database of Systematic Reviews
2012
Corpus ID: 205164501
BACKGROUND Viral warts are a common skin condition, which can range in severity from a minor nuisance that resolve spontaneously…
Expand
Highly Cited
2009
Highly Cited
2009
Catalytic reactions of carbene precursors on bulk gold metal.
Yibo Zhou
,
B. Trewyn
,
R. J. Angelici
,
L. Woo
Journal of the American Chemical Society
2009
Corpus ID: 6263225
Bulk gold metal powder, consisting of particles (5-50 microm) much larger than nanoparticles, catalyzes the coupling of carbenes…
Expand
Highly Cited
2007
Highly Cited
2007
Sensitivity in cancer screening
M. Hakama
,
A. Auvinen
,
N. Day
,
A. Miller
Journal of Medical Screening
2007
Corpus ID: 20303067
Objective: We propose three concepts of sensitivity in cancer screening and apply to data on prostate cancer. Conceptual entities…
Expand
2007
2007
Repeated low‐dose ultraviolet (UV) B exposures of humans induce limited photoprotection against the immune effects of erythemal UVB radiation
J. Narbutt
,
A. Lesiak
,
+8 authors
M. Norval
British Journal of Dermatology
2007
Corpus ID: 7151215
Background Exposure of human subjects to ultraviolet (UV) B radiation causes immunosuppression. Most experiments to date have…
Expand
2007
2007
Synthesis and photophysical properties of novel organo-soluble polyarylates bearing triphenylamine moieties
Guey‐Sheng Liou
,
S. Hsiao
,
Huan-Ming Huang
,
Cha-Wen Chang
,
Hung‐Ju Yen
2007
Corpus ID: 98359137
AbstractTwo series of new blue photoluminescent aromatic polyesters (polyarylates) were synthesized from 4,4…
Expand
2005
2005
Suppression of contact hypersensitivity after repeated exposures of humans to low doses of solar simulated radiation
J. Narbutt
,
A. Lesiak
,
+6 authors
M. Norval
Photochemical and Photobiological Sciences
2005
Corpus ID: 25027747
Although it is generally recognised that UV radiation (UVR) can induce suppression of contact hypersensitivity (CHS) in human…
Expand
2004
2004
Sub-micro level monitoring of beryllium ions with a novel beryllium sensor based on 2,6-diphenyl-4-benzo-9-crown-3-pyridine.
M. Ganjali
,
M. Rahimi‐Nasrabadi
,
+4 authors
M. Namazian
Talanta: The International Journal of Pure and…
2004
Corpus ID: 27097209
2002
2002
Diphencyprone for the treatment of alopecia areata: more data and new aspects.
R. Happle
Archives of Dermatology
2002
Corpus ID: 29469793
1987
1987
Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata.
G. Orecchia
,
Belvedere Mc
,
Miryam Martinetti
,
E. Capelli
,
Giacomo Rabbiosi
Dermatologica
1987
Corpus ID: 22754878
Human leukocyte antigens (HLA) of classes I and II were studied in 127 patients with alopecia areata (AA). The patients were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE